The new coronavirus infection (currently classified as COVID-19), first identified in December 2019 Wuhan, China, has contributed to a significant increase global mortality. Coagulopathy is common disorder COVID-19 patients, which develops parallel with respiratory failure. Currently, continues be life-threatening disease and requires developments solutions define preventive curative strategies...